Cardiac magnetic resonance versus echocardiography: An analysis examining risk reclassification by left ventricular ejection fraction and cost burden analysis.

ABSTRACT:

Background

Heart failure (HF) is a leading cause of morbidity and mortality in the United States and is projected to increase in the next decade. Left ventricular ejection fraction (LVEF) is used to guide optimal medical therapy and is typically quantified using two-dimensional transthoracic echocardiography (TTE) due to ease of accessibility and cost. However, LVEF measurements by cardiovascular magnetic resonance (CMR) are considered the gold standard due to their accuracy and precision. Despite this, CMR is not the first imaging modality selected for LVEF evaluation due to perceptions of long study time, high cost, and inaccessibility. Our study aims to determine the cost of imaging studies (e.g., CMR, TTE) relative to the overall HF-related health care costs and associated outc

SUBMITTER: Tsay AJ 

PROVIDER: S-EPMC12719529 | biostudies-literature | 2025 Winter

REPOSITORIES: biostudies-literature